Nuburu S-1: 25.9M Shares Unleashed by Noteholders, No Proceeds for Company

TL;DR

**Nuburu's S-1 is a red flag: massive dilution from note conversions means no new cash for the company, signaling deep financial distress and a likely continued slide for BURU.**

AI Summary

Nuburu, Inc. (BURUW) has filed an S-1 registration statement to allow selling stockholders to offer up to 25,938,157 shares of common stock. The company will not receive any proceeds from these sales, which include 20,055,588 shares for Indigo Capital LP, 672,881 shares for Brick Lane Capital Management Limited, 1,562,500 shares for Bomore Opportunity Group Ltd, 781,250 shares for Torcross Capital LLC, 2,405,044 shares for 1800 Diagonal Lending LLC, and 460,894 shares for Boot Capital LLC, all issuable upon conversion of promissory notes. Nuburu's common stock trades on the NYSE American under 'BURU', with a last quoted sale price of $0.1630 per share on August 20, 2025. The company is an 'emerging growth company' and faces significant risks, including the ability to obtain financing, maintain NYSE American listing standards, and achieve commercialization. The filing highlights that Nuburu has not yet achieved commercialization, indicating a pre-revenue or early-revenue stage, and emphasizes the high degree of risk for investors.

Why It Matters

This S-1 filing signals a significant potential dilution event for existing Nuburu shareholders, as up to 25,938,157 shares could enter the market from selling stockholders, without any capital infusion for the company. For investors, this means increased supply of shares, potentially depressing the already low share price of $0.1630. Employees and customers might view this as a sign of financial instability, especially given the company's 'emerging growth company' status and lack of commercialization. In the competitive blue laser market, this move could hinder Nuburu's ability to secure future funding or attract strategic partners, as it suggests a reliance on debt conversion rather than operational success.

Risk Assessment

Risk Level: high — The risk level is high because Nuburu explicitly states it 'has not achieved commercialization' and 'will not receive any of the proceeds from the sale of the Common Stock by the selling stockholders.' This indicates a company in a pre-revenue or early-revenue stage, relying on debt conversion for its selling stockholders, rather than equity raises for operational capital. Furthermore, the stock price of $0.1630 per share on August 20, 2025, is well below typical listing requirements, suggesting significant delisting risk.

Analyst Insight

Investors should exercise extreme caution and consider avoiding BURU shares given the substantial potential dilution from 25,938,157 shares entering the market without any capital benefit to the company. Current holders should evaluate their position, as the lack of commercialization and low share price indicate a highly speculative investment with significant downside risk.

Financial Highlights

debt To Equity

N/A

revenue

$0

operating Margin

N/A

total Assets

N/A

total Debt

N/A

net Income

N/A

eps

N/A

gross Margin

N/A

cash Position

N/A

revenue Growth

N/A

Key Numbers

• 25,938,157 — Shares of Common Stock (Maximum shares offered by selling stockholders, representing potential dilution)
• $0.1630 — Share Price (Last quoted sale price for BURU on NYSE American as of August 20, 2025, indicating low market valuation)
• 20,055,588 — Indigo Shares (Shares issuable to Indigo Capital LP upon conversion of promissory notes)
• 672,881 — Brick Lane Shares (Shares issuable to Brick Lane Capital Management Limited upon conversion of promissory notes)
• 1,562,500 — Bomore Shares (Shares issuable to Bomore Opportunity Group Ltd upon conversion of promissory notes)
• 781,250 — Torcross Shares (Shares issuable to Torcross Capital LLC upon conversion of promissory notes)
• 2,405,044 — Diagonal Shares (Shares issuable to 1800 Diagonal Lending LLC upon conversion of promissory notes)
• 460,894 — Boot Shares (Shares issuable to Boot Capital LLC upon conversion of promissory notes)

Key Players & Entities

• Nuburu, Inc. (company) — Registrant and issuer of common stock
• Indigo Capital LP (company) — Selling Stockholder, converting promissory notes for 20,055,588 shares
• Brick Lane Capital Management Limited (company) — Selling Stockholder, converting promissory notes for 672,881 shares
• Bomore Opportunity Group Ltd (company) — Selling Stockholder, converting promissory notes for 1,562,500 shares
• Torcross Capital LLC (company) — Selling Stockholder, converting promissory notes for 781,250 shares
• 1800 Diagonal Lending LLC (company) — Selling Stockholder, converting promissory notes for 2,405,044 shares
• Boot Capital LLC (company) — Selling Stockholder, converting promissory notes for 460,894 shares
• Alessandro Zamboni (person) — Executive Chairman of Nuburu, Inc.
• NYSE American (regulator) — Exchange where Nuburu's common stock is traded
• U.S. Securities and Exchange Commission (regulator) — Regulatory body for the S-1 filing

FAQ

Risk Factors

• Selling Stockholder Dilution [high — financial]: The registration statement allows for the sale of up to 25,938,157 shares of common stock by selling stockholders. This includes a significant portion of 20,055,588 shares for Indigo Capital LP, all issuable upon conversion of promissory notes. The company receives no proceeds from these sales, indicating potential dilution for existing shareholders and a focus on debt conversion rather than new capital infusion.
• Lack of Commercialization [high — operational]: Nuburu, Inc. has not yet achieved commercialization, indicating it is in a pre-revenue or early-revenue stage. This presents a significant risk as the company's ability to generate substantial revenue and achieve profitability is unproven.
• Financing Needs and Uncertainty [high — financial]: The company faces significant risks related to its ability to obtain necessary financing. As an emerging growth company with unproven commercialization, securing future funding on favorable terms is uncertain and critical for its continued operations and growth.
• NYSE American Listing Standards [medium — regulatory]: Maintaining compliance with NYSE American listing standards is a significant risk. Failure to meet these standards could result in delisting, severely impacting the liquidity and marketability of the company's common stock.

Industry Context

Nuburu operates in a highly competitive and rapidly evolving sector, likely related to advanced materials or manufacturing technologies given its focus on innovation. The industry demands significant R&D investment and faces challenges in scaling production and achieving market adoption. Key trends include the drive for sustainable solutions and performance enhancements, where companies like Nuburu aim to differentiate through proprietary technology.

Regulatory Implications

As an emerging growth company filing an S-1, Nuburu is subject to SEC regulations regarding disclosures and public offerings. The company must also adhere to NYSE American listing requirements, which include financial and governance standards. Failure to comply with these regulations could lead to penalties or delisting.

What Investors Should Do

1. Scrutinize the terms of the promissory notes and the conversion mechanisms for the selling stockholders' shares.
2. Assess the company's path to commercialization and its financial projections, if any, with extreme caution.
3. Monitor the company's ability to maintain its NYSE American listing.
4. Consider the dilutive impact of the potential sale of up to 25,938,157 shares.

Glossary

S-1 Registration Statement

A form filed with the SEC by companies that intend to offer securities to the public. It provides detailed information about the company's business, financial condition, and the securities being offered. (This filing indicates Nuburu is preparing to allow selling stockholders to offer shares, and it contains all the detailed disclosures about the company's status and risks.)

Selling Stockholders

Existing shareholders who are offering their shares for sale to the public, as opposed to the company itself selling newly issued shares. (In this case, the S-1 is for selling stockholders, meaning Nuburu will not receive any proceeds from the sale of these shares, which are primarily tied to promissory note conversions.)

Promissory Notes

A written promise by one party (the maker or issuer) to pay a definite sum of money to another party (the payee), either on demand or at a specified future date. (A significant portion of the shares being offered are issuable upon the conversion of promissory notes held by entities like Indigo Capital LP, indicating past financing arrangements.)

Emerging Growth Company

A designation under the JOBS Act for companies with less than $1.235 billion in annual gross revenue that have gone public in the last five years. These companies are allowed certain regulatory and disclosure accommodations. (Nuburu's status as an EGC highlights its early stage and potential for reduced disclosure requirements, but also implies a higher risk profile.)

Commercialization

The process of bringing a new product, service, or technology to the market and making it available for sale to customers. (The S-1 explicitly states that Nuburu has not yet achieved commercialization, which is a critical risk factor as it means the company's business model and revenue generation are unproven.)

Year-Over-Year Comparison

This S-1 filing focuses on the registration of shares for sale by existing stockholders, primarily arising from promissory note conversions. Unlike a typical IPO or follow-on offering where the company raises capital, Nuburu will not receive proceeds from these sales. The filing highlights the company's pre-commercialization status and significant risks, including financing needs and maintaining exchange listing, which are likely consistent or amplified compared to previous disclosures given the lack of revenue generation.

Key Financial Figures

• $0.0001 — 8,157 shares of common stock, par value $0.0001 per share ("Common Stock"), of Nuburu,
• $0.1630 — ck as reported on the NYSE American was $0.1630 per share. We have not listed, nor do w
• $0.01 — to Anzu Partners with a strike price of $0.01 per share for 500,000 shares of Preferr
• $1,578,495 — : A convertible note in the amount of $1,578,495, issued on March 3, 2025, that bears no
• $1,500,000 — note was issued in exchange for funding $1,500,000 of the Company's obligations in connect
• $367,554 — this note, the remaining face amount is $367,554 as of August 20, 2025. A convertible
• $894,708 — . A convertible note in the amount of $894,708, issued on March 3, 2025, that bears no
• $394,585 — this note, the remaining face amount is $394,585 as of August 20, 2025. A convertible
• $1,421,053 — . A convertible note in the amount of $1,421,053, issued on April 22, 2025, that bears n
• $1,350,000 — d in exchange for a capital infusion of $1,350,000 to the Company. A convertible note in
• $2,108,523 — . A convertible note in the amount of $2,108,523, issued on April 22, 2025, that bears n
• $2,003,097 — d promissory note of the Company with a $2,003,097 face amount. A convertible note in th
• $150,000 — . A convertible note in the amount of $150,000, issued on July 16, 2025, that bears no
• $225,000 — . A convertible note in the amount of $225,000, issued on August 18, 2025, that bears

Filing Documents

• buru-20250829.htm (S-1) — 8656KB
• buru-ex5_1.htm (EX-5.1) — 38KB
• buru-ex23_1.htm (EX-23.1) — 5KB
• buru_exfilingfees.htm (EX-FILING FEES) — 140KB
• img54696167_0.jpg (GRAPHIC) — 12KB
• img208656848_0.jpg (GRAPHIC) — 23KB
• 0000950170-25-112268.txt ( ) — 32388KB
• buru-20250829.xsd (EX-101.SCH) — 3179KB
• buru-20250829_htm.xml (XML) — 7274KB
• buru_exfilingfees_htm.xml (XML) — 8KB

Risk Factors

Risk Factors 9 Transactions with Selling Stockholders 26

Use of Proceeds

Use of Proceeds 28 Determination of Offering Price 28 Market for Common Stock and Dividend Policy 28 Our Business 28

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 38 Selling Stockholders 57

Description of Securities to Be Registered

Description of Securities to Be Registered 59

Legal Proceedings

Legal Proceedings 61 Executive Officers, Directors and Director Independence 62

Executive Compensation

Executive Compensation 64 Director Compensation 67

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 69 Certain Relationships and Related Party Transactions 71 Plan of Distribution 81 Legal Matters 83 Experts 83 Where You Can Find More Information 83 Incorporation of Certain Information by Reference 83 Index to Financial Statements F- 1 i About T his Prospectus This prospectus is part of a registration statement on Form S-1 that we filed with the U.S. Securities and Exchange Commission (the "SEC"). Under this registration process, the Selling Stockholders may, from time to time, sell the securities described in this prospectus. We will not receive any proceeds from the sale by the Selling Stockholders of the securities offered in this prospectus. We may also file a prospectus supplement or post-effective amendment to the registration statement of which this prospectus forms a part that may contain material information relating to this offering. The prospectus supplement or post-effective amendment may also add, update or change information contained in this prospectus. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement or post-effective amendment, you should rely on the prospectus supplement or post-effective amendment, as applicable. Before purchasing any securities, you should carefully read this prospectus, any post-effective amendment, and any applicable prospectus supplement, together with the additional information described under the headings " Where You Can Find More Information ". Neither we nor the Selling Stockholders have authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus, any post-effective amendment, or any applicable prospectus supplement prepared by or on behalf of us or to which we have referred you. We and the Selling Stockholders take no responsibility for and can provide no assurance as to the reliabilit

View Full Filing

View this S-1 filing on SEC EDGAR